Login / Signup

Long-term longevity and clinical outcomes of Linox S/SD implantable cardioverter-defibrillator leads: a single-center experience.

Mohammad AlastiColin MachadoSam MirzaeeStewart HealyLogan BittingerDavid AdamEmily KotschetJack KrafchekJeffrey Alison
Published in: Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing (2020)
At our center, the 5-year lead survival of the Linox S/SD has been better than reports from other centers. The majority of lead failures presented as non-physiological high-rate sensing with subsequent inappropriate therapy.
Keyphrases
  • emergency department
  • adverse drug
  • stem cells
  • mesenchymal stem cells